%A Yu,Christopher %A Pathan,Faraz %A Tan,Timothy C. %A Negishi,Kazuaki %D 2021 %J Frontiers in Cardiovascular Medicine %C %F %G English %K Cardio-oncology,cardiotoxicity,cardiac imaging,Echocardiogaphy,Cardiac magnet resonance imaging (CMR),Global longitudinal strain,Cancer,Cardiac computer tomographic (CT) imaging,cancer therapeutics related cardiac dysfunction,Cancer therapy related cardiac dysfunction (CTRCD) %Q %R 10.3389/fcvm.2021.728215 %W %L %M %P %7 %8 2021-September-03 %9 Mini Review %# %! Cardiac imaging in cardio-oncology %* %< %T The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments %U https://www.frontiersin.org/articles/10.3389/fcvm.2021.728215 %V 8 %0 JOURNAL ARTICLE %@ 2297-055X %X Cardio-oncology encompasses the risk stratification, prognostication, identification and management of cancer therapeutics related cardiac dysfunction (CTRCD). Cardiovascular imaging (CVI) plays a significant role in each of these scenarios and has broadened from predominantly quantifying left ventricular function (specifically ejection fraction) to the identification of earlier bio-signatures of CTRCD. Recent data also demonstrate the impact of chemotherapy on the right ventricle, left atrium and pericardium and highlight a possible role for CVI in the identification of CTRCD through tissue characterization and assessment of these cardiac chambers. This review aims to provide a contemporary perspective on the role of multi-modal advanced cardiac imaging in cardio-oncology.